Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

GLP-1 RA medications may be linked to hair loss.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

A cream with a specific hormone blocker increases hair growth in mice.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.